Posts
May 01 2017
The Deal issued its quarterly PIPE league tables, revealing that 2017’s first quarter outperformed last year’s first quarter. Deals were up nearly 75% from the previous year to 367, while dollars raised were up almost 70% to $21.3 billion.
EG&S is top ranked. Click here to read the article.
May 01 2017
CytRx Corporation announced the closing of their Registered Direct in the amount of $15,000,000. EG&S acted as counsel to the Placement Agent.
April 28 2017
BioPharm X Corporation announced the closing of their Registered Direct offering in the amount of $5,000,001. EG&S acted as counsel to the lead Investor.
April 27 2017
Aeterna Zentaris Inc. announced the implementation of their At the Market offering in the amount of $6,944,000. EG&S acted as counsel to the Placement Agent.
April 26 2017
Apricus Biosciences, Inc. announced the closing of their Underwritten offering in the amount of $7,042,000. EG&S acted as counsel to the Underwriter.
April 24 2017
Sunshine Heart, Inc. announced the closing of their Underwritten offering in the amount of $8,372,000. EG&S acted as counsel to the Underwriter.
April 21 2017
Social Reality Inc. announced the closing of their PIPE offering in the amount of $5,000,000. EG&S acted as counsel to the lead Investor.
April 19 2017
DelMar Pharmaceuticals, Inc. announced the closing of their Registered Direct offering in the amount of $9,000,000. EG&S acted as counsel to the Placement Agent.